Viatris and Opus Genetics report MR-141 met efficacy and safety goals in Phase 3 VEGA-3 trial for presbyopia, with strong patient-reported benefits.
Viatris Eye Drops Data Shows Promise For Blurred Near Vision
Where Today's News Shapes Tomorrow
February 19, 2026
Headlines
